177 related articles for article (PubMed ID: 26223682)
1. Stratifin accelerates progression of lung adenocarcinoma at an early stage.
Shiba-Ishii A; Kim Y; Shiozawa T; Iyama S; Satomi K; Kano J; Sakashita S; Morishita Y; Noguchi M
Mol Cancer; 2015 Jul; 14():142. PubMed ID: 26223682
[TBL] [Abstract][Full Text] [Related]
2. Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Ramirez K; Muratani M; Sakamoto N; Iijima T; Noguchi M
Cancer Sci; 2019 Aug; 110(8):2431-2441. PubMed ID: 31144406
[TBL] [Abstract][Full Text] [Related]
3. Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.
Shiba-Ishii A
Pathol Int; 2021 Oct; 71(10):655-665. PubMed ID: 34324245
[TBL] [Abstract][Full Text] [Related]
4. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma.
Shiba-Ishii A; Kano J; Morishita Y; Sato Y; Minami Y; Noguchi M
Int J Cancer; 2011 Nov; 129(10):2445-53. PubMed ID: 21207417
[TBL] [Abstract][Full Text] [Related]
5. Stratifin Inhibits SCF
Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
[TBL] [Abstract][Full Text] [Related]
6. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
7. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
[TBL] [Abstract][Full Text] [Related]
8. Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.
Sirivatanauksorn V; Dumronggittigule W; Dulnee B; Srisawat C; Sirivatanauksorn Y; Pongpaibul A; Masaratana P; Somboonyosdech C; Sripinitchai S; Kositamongkol P; Mahawithitwong P; Tovikkai C; Sangserestid P; Limsrichamrern S
Surg Oncol; 2020 Mar; 32():57-62. PubMed ID: 31751820
[TBL] [Abstract][Full Text] [Related]
9. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
10. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
12. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
13. Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.
Huang J; Wang L; Jiang M; Chen Q; Zhang X; Wang Y; Jiang Z; Zhang Z
Immunol Res; 2016 Apr; 64(2):461-9. PubMed ID: 26423071
[TBL] [Abstract][Full Text] [Related]
14. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
Patlolla JM; Kopelovich L; Qian L; Zhang Y; Kumar G; Madka V; Mohammed A; Biddick L; Sadeghi M; Lightfoot S; Rao CV
Oncol Rep; 2015 Dec; 34(6):2925-34. PubMed ID: 26397133
[TBL] [Abstract][Full Text] [Related]
15. ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.
Kossmann CM; Annereau M; Thomas-Schoemann A; Nicco-Overney C; Chéreau C; Batteux F; Alexandre J; Lemare F
Tumour Biol; 2017 Jul; 39(7):1010428317716077. PubMed ID: 28675123
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells.
Ehrhardt A; Bartels T; Klocke R; Paul D; Halter R
J Cancer Res Clin Oncol; 2003 Feb; 129(2):71-5. PubMed ID: 12669230
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma.
Robin F; Angenard G; Cano L; Courtin-Tanguy L; Gaignard E; Khene ZE; Bergeat D; Clément B; Boudjema K; Coulouarn C; Sulpice L
Br J Cancer; 2020 Jul; 123(1):72-80. PubMed ID: 32376891
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
19. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
